title: Aspergillus oryzae lectin induces anaphylactoid oedema and mast cell activation through its interaction with fucose of mast cell-bound non-specific IgE.
abstract: We investigated whether Aspergillus oryzae lectin (AOL), a fucose-specific lectin, induces anaphylactoid reactions and mast cell activation. The injection of AOL into footpads of mice produced a dose-related acute paw oedema. The AOL-induced oedema was attenuated by predose of histamine H1 receptor blocker or pretreatment of the lectin with fucose before injection and was not observed in SCID and mast cell-deficient WBB6F1-W/Wv mice. These results suggested that the AOL-induced anaphylactoid reaction was mediated by histamine released from mast cells. In addition, the activation of mast cells was seemed to be induced by the crosslinking of IgE on the cell surface following the binding of AOL to fucose residues in IgE. Consistent with the in vivo results, AOL induced the degranulation of the rat mast cell line RBL2H3 sensitized with monoclonal IgE. As AOL induced the increase in intracellular Ca(2+)  concentration of IgE-sensitized RBL2H3 cells as well as antigen stimulation, AOL could input signals from FcεRI. The degranulation of IgE-sensitized RBL2H3 cells by AOL was diminished by pretreatment of AOL with fucose. Defucosylated IgE did not induce degranulation of RBL2H3 cells in response to AOL stimulation, in spite of its ability to induce degranulation by antigen stimulation as intact IgE. These results indicated that AOL bound to fucose residue of IgE causing antigen-independent IgE-mediated mast cell activation and anaphylactoid reactions in vitro and in vivo, respectively. AOL bound to human IgE as well as to mouse IgE, suggesting the possible implication of AOL in the allergic response to Aspergillus oryzae in humans.
authors.affiliation: Department of Pharmacology, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Hyogo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yamaki
authors.forename: S
authors.initials: S
authors.lastname: Yoshino
mesh_terms: D000707:Anaphylaxis; D000818:Animals; D001236:Aspergillus oryzae / Q000276:immunology*; D020013:Calcium Signaling / Q000187:drug effects; D015550:Cell Degranulation / Q000187:drug effects; D002460:Cell Line; D004195:Disease Models, Animal; D004487:Edema; D005643:Fucose / Q000737:chemistry / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D007114:Immunization; D007073:Immunoglobulin E / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D037102:Lectins / Q000008:administration & dosage* / Q000819:agonists / Q000737:chemistry; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D016513:Mice, SCID; D051381:Rats
chemical_list: D006634:Histamine H1 Antagonists; D037102:Lectins; D005643:Fucose; D007073:Immunoglobulin E